網易遊戲「520」線上發布會結束 共推46款產品
2023年網易遊戲「520」線上發布會於近期圓滿結束。此次網易(09999.HK)(NTES.US)旗下網易遊戲發布11款新遊戲、35款熱門遊戲/IP及平台產品。其中11款新品不僅涵蓋武俠、奇幻、射擊、體育等題材,在畫面風格、玩法上也各有千秋。
例如,借助高技術支持、打造出色視覺與玩法的《逆水寒》手遊、以金庸筆下的武俠開放世界探索為特色的《射雕》、能夠體驗到東方文明奇幻冒險的《九畿:岐風之旅》,另類暗黑三國風格的《三國誅將錄》等。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.